FDA Approves Glutamine Powder for Sickle Cell Disease | oneSCDvoice
  • Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials

FDA Approves Glutamine Powder for Sickle Cell Disease


The U.S. Food and Drug Administration (FDA) has approved Emmaus Life Sciences’ Endari (L-glutamine oral powder) for the treatment of sickle cell disease.

More specifically, the powder formulation is approved for patients ages 5 years and older with sickle cell disease to reduce severe complications associated with the blood disorder.

Sickle cell disease is a rare genetic condition that affects 90,000 to 100,000 Americans, most of whom are African Americans. A person with sickle cell disease has red blood cells that are hard, sticky, and C-shaped (like the farm tool the “sickle”).

https://www.onescdvoice.com/wp-content/uploads/2017/11/1.png